CJC1295+DAC 5mg Australia | Silverback Peptides – Research Use Only

CJC-1295 + DAC 5mg is a synthetic peptide supplied by Silverback Peptides for laboratory, scientific, and investigational research. CJC-1295 with Drug Affinity Complex (DAC) is a modified growth hormone-releasing hormone (GHRH) analogue that has been studied for its interaction with GHRH receptors and related signalling pathways.

Supplied as a lyophilised powder, CJC-1295 + DAC 5mg is intended exclusively for controlled laboratory research involving peptide activity, receptor interactions, endocrine signalling, and related biological pathways.

For research use only. Not for human or veterinary use.

CJC-1295 + DAC Research Overview

CJC-1295 with DAC has been investigated in scientific research as a long-acting GHRH analogue. The DAC modification has been studied in relation to peptide stability and interaction with biological targets.

Product Specifications

• Product: CJC-1295 + DAC
• Quantity: 5mg
• Form: Lyophilised powder
• Brand: Silverback Peptides
• Location: Australia
• Intended use: Laboratory and scientific research only

Research Use Only

CJC-1295 + DAC 5mg is supplied exclusively for laboratory and investigational research purposes. It is not intended for human consumption, veterinary use, diagnosis, treatment, prevention, or management of any medical condition.

Researchers are responsible for ensuring appropriate handling, storage, testing, and use in accordance with applicable laboratory procedures and regulations.

For laboratory research only. Not for human or veterinary use.